Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Precision Medicine For Pseudomonas Spurs Polyphor's Swiss IPO Plans

Apr 10 2018

Allschwil — Allschwil is just outside Basel, Switzerland's pharma hub • Source: Shutterstock

Related Content

BioLineRx's CXCR4 Antagonist: Promising For Stem Cell Mobilization And AML

Dec 05 2017

Santhera Expands Pipeline With Polyphor Cystic Fibrosis Deal

Feb 16 2018

Polyphor Pursues Promise Of Inhaled Antibiotics To Tackle Lung Infections

Oct 12 2017

Related Companies

Polyphor AG

Galena Biopharma, Inc.

Idorsia Pharmaceuticals Ltd

Actelion Pharmaceuticals Ltd.

Santhera Pharmaceuticals

Additional Topics

Switzerland Europe Financing Commercial ImmunoOncology StartUps and SMEs Infectious Diseases BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.